From the junctions that hold cells together to the bacteria that cause pneumonia, fascinating scientific images provide a window into the wide range of research that Feinberg faculty, trainees and students published in 2015.
Yearly Archives: 2015
Northwestern Medicine scientists discovered that nitric oxide is part of a new form of cell learning in the striatum, the region of the brain involved in the symptoms of Parkinson’s disease and schizophrenia.
A randomized clinical trial showed an intravitreous drug may be an alternative treatment for some patients with proliferative diabetic retinopathy.
A recent study co-authored by Northwestern Medicine scientist Robert Goldman, PhD, and colleagues suggests that degradation of lamin B1, a protein located in the nucleus of cells, helps suppress tumor formation.
A brain region controlling whether we feel happy or sad, as well as addiction, is remodeled by chronic pain, according to a new Northwestern Medicine study, and a new treatment targeting this region may dramatically lessen symptoms.
The Fall and Winter issue of Northwestern Research Magazine, which highlights the discoveries of Northwestern scholars, focuses on interdisciplinary cognitive science, including several Feinberg scientists.
A new Northwestern Medicine study addresses challenges at the PhD level to boost the persistence of underrepresented minority and female students toward academic careers.
Injections of botulinum toxin improved active arm movement for stroke and brain trauma patients in a clinical trial that involved Northwestern Medicine co-investigator Christina Marciniak, MD, ’85 GME.
Douglas Wilcox, a student in the Medical Scientist Training Program, discovered the herpes simplex virus targets a host cell protein to cause severe disease and encephalitis in newborns.
A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.